These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 35131348)

  • 21. Implications of Shortened Quarantine Among Household Contacts of Index Patients with Confirmed SARS-CoV-2 Infection - Tennessee and Wisconsin, April-September 2020.
    Rolfes MA; Grijalva CG; Zhu Y; McLean HQ; Hanson KE; Belongia EA; Halasa NB; Kim A; Meece J; Reed C; Talbot HK; Fry AM
    MMWR Morb Mortal Wkly Rep; 2021 Jan; 69(5152):1633-1637. PubMed ID: 33382676
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of Day-7 Postexposure Testing of Asymptomatic Contacts of COVID-19 Patients to Evaluate Early Release from Quarantine - Vermont, May-November 2020.
    Jones A; Fialkowski V; Prinzing L; Trites J; Kelso P; Levine M
    MMWR Morb Mortal Wkly Rep; 2021 Jan; 70(1):12-13. PubMed ID: 33411700
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SARS-CoV-2 seroprevalence in oncology healthcare professionals and patients with cancer at a tertiary care centre during the COVID-19 pandemic.
    Fuereder T; Berghoff AS; Heller G; Haslacher H; Perkmann T; Strassl R; Berger JM; Puhr HC; Kreminger J; Moik F; Schubert L; Starzer AM; Steindl A; Winkler S; Preusser M; Tobudic S
    ESMO Open; 2020 Sep; 5(5):e000889. PubMed ID: 32878898
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Seroprevalence of SARS-CoV-2 Among Frontline Health Care Personnel in a Multistate Hospital Network - 13 Academic Medical Centers, April-June 2020.
    Self WH; Tenforde MW; Stubblefield WB; Feldstein LR; Steingrub JS; Shapiro NI; Ginde AA; Prekker ME; Brown SM; Peltan ID; Gong MN; Aboodi MS; Khan A; Exline MC; Files DC; Gibbs KW; Lindsell CJ; Rice TW; Jones ID; Halasa N; Talbot HK; Grijalva CG; Casey JD; Hager DN; Qadir N; Henning DJ; Coughlin MM; Schiffer J; Semenova V; Li H; Thornburg NJ; Patel MM; ;
    MMWR Morb Mortal Wkly Rep; 2020 Sep; 69(35):1221-1226. PubMed ID: 32881855
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surveillance and return to work of healthcare workers following SARS-CoV-2 Omicron variant infection, Sheffield, England, 17 January to 7 February 2022.
    Raza M; Giri P; Basu S
    Euro Surveill; 2022 Mar; 27(11):. PubMed ID: 35301977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. International travel-related control measures to contain the COVID-19 pandemic: a rapid review.
    Burns J; Movsisyan A; Stratil JM; Biallas RL; Coenen M; Emmert-Fees KM; Geffert K; Hoffmann S; Horstick O; Laxy M; Klinger C; Kratzer S; Litwin T; Norris S; Pfadenhauer LM; von Philipsborn P; Sell K; Stadelmaier J; Verboom B; Voss S; Wabnitz K; Rehfuess E
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013717. PubMed ID: 33763851
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An early return-to-work program for COVID-19 close contacts in healthcare during the Omicron wave in Japan.
    Naruse H; Doi Y; Iwata M; Ishikawa K
    J Infect Chemother; 2023 Jan; 29(1):102-104. PubMed ID: 36087922
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of Test to Stay Strategy on Secondary and Tertiary Transmission of SARS-CoV-2 in K-12 Schools - Lake County, Illinois, August 9-October 29, 2021.
    Nemoto N; Dhillon S; Fink S; Holman EJ; Cope AK; Dinh TH; Meadows J; Taryal D; Akindileni F; Franck M; Gelber E; Bacci L; Ahmed S; Thomas ES; Neatherlin JC
    MMWR Morb Mortal Wkly Rep; 2021 Dec; 70(5152):1778-1781. PubMed ID: 34968375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidemiology of SARS-CoV-2 antibodies among firefighters/paramedics of a US fire department: a cross-sectional study.
    Caban-Martinez AJ; Schaefer-Solle N; Santiago K; Louzado-Feliciano P; Brotons A; Gonzalez M; Issenberg SB; Kobetz E
    Occup Environ Med; 2020 Dec; 77(12):857-861. PubMed ID: 32764107
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Examining Common Characteristics Among Healthcare Personnel Positive for COVID-19 and the Effectiveness of Healthcare Personnel Mask Use in Preventing COVID-19 in a Large Health System in Central Michigan.
    Adawee MO; Brum RE; Ellsworth LJ
    J Occup Environ Med; 2021 Mar; 63(3):226-229. PubMed ID: 33156134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Strategies to reduce the risk of SARS-CoV-2 importation from international travellers: modelling estimations for the United Kingdom, July 2020.
    Clifford S; Quilty BJ; Russell TW; Liu Y; Chan YD; Pearson CAB; Eggo RM; Endo A; ; Flasche S; Edmunds WJ;
    Euro Surveill; 2021 Sep; 26(39):. PubMed ID: 34596018
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does the CDC COVID-19 Exposure Assessment Criteria for Healthcare Personnel Work in a Healthcare Setting in Pakistan?
    Hassan I; Khan UI; Ali S; Hakim A; Ali A
    J Coll Physicians Surg Pak; 2023 Jan; 33(1):53-58. PubMed ID: 36597236
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.
    Barnabas RV; Brown E; Bershteyn A; Miller RS; Wener M; Celum C; Wald A; Chu H; Wesche D; Baeten JM;
    Trials; 2020 Jun; 21(1):475. PubMed ID: 32493478
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk Factors for SARS-CoV-2 Infection Among US Healthcare Personnel, May-December 2020.
    Chea N; Brown CJ; Eure T; Ramirez RA; Blazek G; Penna AR; Li R; Czaja CA; Johnston H; Barter D; Miller BF; Angell K; Marshall KE; Fell A; Lovett S; Lim S; Lynfield R; Davis SS; Phipps EC; Sievers M; Dumyati G; Concannon C; McCullough K; Woods A; Seshadri S; Myers C; Pierce R; Ocampo VLS; Guzman-Cottrill JA; Escutia G; Samper M; Thompson ND; Magill SS; Grigg CT
    Emerg Infect Dis; 2022 Jan; 28(1):95-103. PubMed ID: 34856114
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Returning to Work after the COVID-19 Pandemic Earthquake: A Systematic Review.
    Garzillo EM; Cioffi A; Carta A; Monaco MGL
    Int J Environ Res Public Health; 2022 Apr; 19(8):. PubMed ID: 35457407
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Point-of-Care COVID-19 Antigen Testing in Exposed German Healthcare Workers-A Cost Model.
    Diel R; Hittel N; Nienhaus A
    Int J Environ Res Public Health; 2021 Oct; 18(20):. PubMed ID: 34682514
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
    Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
    Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Occupational exposure to severe acute respiratory coronavirus virus 2 (SARS-CoV-2) and risk of infection among healthcare personnel.
    Shah VP; Breeher LE; Alleckson JM; Rivers DG; Wang Z; Stratton ER; Farah W; Hainy CM; Swift MD
    Infect Control Hosp Epidemiol; 2022 Dec; 43(12):1785-1789. PubMed ID: 34986906
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pre-exposure prophylaxis with hydroxychloroquine for high-risk healthcare workers during the COVID-19 pandemic: A structured summary of a study protocol for a multicentre, double-blind randomized controlled trial.
    Grau-Pujol B; Camprubí D; Marti-Soler H; Fernández-Pardos M; Guinovart C; Muñoz J
    Trials; 2020 Jul; 21(1):688. PubMed ID: 32727613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.